Tillotson GS - Search Results

1

Efficacy of ciprofloxacin and clarithromycin in acute bacterial exacerbations of complicated chronic bronchitis: interim analysis. Bronchitis Study Group.

Anzueto A, Niederman MS, Haverstock DC, Tillotson GS. Anzueto A, et al. Among authors: tillotson gs. Clin Ther. 1997 Sep-Oct;19(5):989-1001. doi: 10.1016/s0149-2918(97)80051-3. Clin Ther. 1997. PMID: 9385486 Clinical Trial.

2

Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: ciprofloxacin 750 mg b.i.d. versus clarithromycin 500 mg b.i.d. Bronchitis Study Group.

Anzueto A, Niederman MS, Tillotson GS. Anzueto A, et al. Among authors: tillotson gs. Clin Ther. 1998 Sep-Oct;20(5):885-900. doi: 10.1016/s0149-2918(98)80071-4. Clin Ther. 1998. PMID: 9829441 Free article. Clinical Trial.

3

Acute exacerbation of COPD: factors associated with poor treatment outcome.

Dewan NA, Rafique S, Kanwar B, Satpathy H, Ryschon K, Tillotson GS, Niederman MS. Dewan NA, et al. Among authors: tillotson gs. Chest. 2000 Mar;117(3):662-71. doi: 10.1378/chest.117.3.662. Chest. 2000. PMID: 10712989

4

Multicenter comparative trial of ciprofloxacin versus cefuroxime axetil in the treatment of acute rhinosinusitis in a primary care setting. Rhinosinusitis Investigation Group.

Weis M, Hendrick K, Tillotson G, Gravelle K. Weis M, et al. Clin Ther. 1998 Sep-Oct;20(5):921-32. doi: 10.1016/s0149-2918(98)80074-x. Clin Ther. 1998. PMID: 9829444 Clinical Trial.

5

The efficacy of moxifloxacin in acute exacerbations of chronic bronchitis: a Spanish physician and patient experience.

Miravitlles M, Ros F, Cobos A, Kubin R, Tillotson G. Miravitlles M, et al. Int J Clin Pract. 2001 Sep;55(7):437-41. Int J Clin Pract. 2001. PMID: 11594251 Clinical Trial.

6

Chemotherapy for chronic bronchitis. Controversies.

Ball P, Tillotson G, Wilson R. Ball P, et al. Presse Med. 1995 Jan 21;24(3):189-94. Presse Med. 1995. PMID: 7899359 Review.

7

Treatment outcomes in acute exacerbations of chronic bronchitis: comparison of macrolides and moxifloxacin from the patient perspective.

Lorenz J, Thate-Waschke IM, Mast O, Kubin R, Rychlik R, Pfeil T, Daniel D, Tillotson GS. Lorenz J, et al. Among authors: tillotson gs. J Int Med Res. 2001 Mar-Apr;29(2):74-86. doi: 10.1177/147323000102900204. J Int Med Res. 2001. PMID: 11393351 Free article. Clinical Trial.

8

Treatment of acute exacerbations of chronic obstructive airways disease--a comparison of amoxycillin and ciprofloxacin.

Basran GS, Joseph J, Abbas AM, Hughes C, Tillotson GS. Basran GS, et al. Among authors: tillotson gs. J Antimicrob Chemother. 1990 Dec;26 Suppl F:19-24. doi: 10.1093/jac/26.suppl_f.19. J Antimicrob Chemother. 1990. PMID: 2292540 Clinical Trial.

9

Lower respiratory tract infection therapy--the role of ciprofloxacin.

Ball AP, Tillotson GS. Ball AP, et al. Among authors: tillotson gs. J Int Med Res. 1995 Sep-Oct;23(5):315-27. doi: 10.1177/030006059502300501. J Int Med Res. 1995. PMID: 8529774 Review.

10

Associations between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in a private, university-affiliated teaching hospital: an 8-year-experience: 1995-2002.

Mohr JF, Jones A, Ostrosky-Zeichner L, Wanger A, Tillotson G. Mohr JF, et al. Int J Antimicrob Agents. 2004 Oct;24(4):346-51. doi: 10.1016/j.ijantimicag.2004.06.002. Int J Antimicrob Agents. 2004. PMID: 15380259

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

175 results

Search Page

Filters